Flávia Martinello is Member of SBAC – Brazilian Society of Clinical Analysis.
Next IFCC webinar on “Quality in Clinical Laboratories” will be held on June 15, 2021.
It is widely recognized that errors in laboratory medicine could significantly compromise patient safety independently of time, place and measurement procedure. All clinical laboratories have to implement measures to detect high-risk processes, and to identify incidents and associated risks to patient safety. A wide number of instruments have been implemented to maintain the so-called “quality” of the process in clinical laboratories, and recently the IFCC have created a new task force on Global Lab Quality with the aim of providing scientific support teams to train and develop training programs for participating laboratories.
Certificate of participation will be provided at the end of this webinar.
Please ensure you register to attend the live event and have access to the recording and to the certificate.
Schedule: 20 min per speaker plus 20 min panel discussion
Time Zones: Live presentations starting at: 9:00AM EDT – 10:00AM Buenos Aires- AR; 3:00PM European Time; 9:00PM CST-Beijing.
Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. Click here to convert to your time-zone:
Recorded webinar: available on demand
Certificate of Participation: available for all registrants
Register for the new EFLM Academy webinar: Myths and facts about vitamin D on June 15, 2021 at 18:00 CET
Register at elearning.eflm.eu/login/index.php
The webinar is accessible for EFLM Academy members only.
Register for next IFCC webinar on “Clinical Applications of Thrombosis and Hemostasis”
Date and Time: June 6, 2021, 7:00 AM Eastern Time US; 1:00 PM Central European Time, 7:00 PM Beijing Time
Thrombosis and hemostasis tests are of importance for the diagnosis of hemorrhagic diseases and disseminated intravascular coagulation (DIC). They are laboratory determinants for the mechanism of thrombosis occurrence, the classification and diagnosis of thrombotic diseases and thrombophilia, as well as the indices of the monitoring of anticoagulant therapy. Several studies showed that thromboembolic events were a serious complication of coronavirus disease 2019 (COVID-19). Autopsy revealed that the death was associated with pulmonary thromboembolism and DIC. In this webinar will provide an overview on the clinical application of thrombosis and hemostasis tests in the monitoring of new oral anticoagulants, in the diagnosis of thrombosis and hemostasis, and the performance of thrombosis and hemostasis tests in COVID-19 patients.
Please ensure you register to attend the live event and have access to the recording and to the certificate.
Registration link is: www.workcast.com/register?cpak=6876560247232785
10th May, 2021
Register at: https://www.workcast.com/register?cpak=3071202974282642
This webinar will provide an overview of risk management in healthcare focusing on clinical laboratories. The presentations will provide an explanation of how Risk Management is done and highlight Risk Management frameworks like Failure Modes and Effects Analysis (FMEA), Root Cause Analysis (RCA), and others. The webinar will contain three presentations of 20 min per speaker plus 20 min panel discussion.
Chair/Moderator: Prof. Sedef Yenice (Turkey)
Register to attend the live event, to access to the on demand content
and get your certificate of participation.
Schedule: 20 min per speaker plus 20 min panel discussion
Time Zones: Live presentations starting at 06:30 PM (India), 3:00 PM (Central Europe), 09:00 AM (US Eastern time)
Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. To calculate this, you can use the time zone converter tool at: www.timeanddate.com/worldclock/converter.html.
Recorded webinar: available on demand
Certificate of Participation: available for all participants
Dr. Adeli is the Head of Clinical Biochemistry in the Department of Paediatric Laboratory Medicine, as well as a Senior Scientist in the Molecular Medicine Program of the Research Institute, at the Hospital for Sick Children in Toronto, Canada. He is also the current President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
Since 1988, Dr. Adeli has been actively involved in molecular and clinical laboratory research. This past year, he has made significant contributions to the fight against COVID-19, which include the establishment of the IFCC Global Taskforce on COVID-19 to summarize, critically review, and disseminate the most up-to-date, evidence-based information about the novel coronavirus as well as provide recommendations regarding test implementation. Recently, he also initiated a COVID-19 Surveillance Program to monitor active infection and serological response in students of Toronto and surrounding areas.
Professor Damien Gruson is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc, Brussels. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain.
Pr. D. Gruson is member of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Fellow of the European Society of Cardiology.
In the frame of the EFLM Scholarship Programme in memory of Prof. Vic Blaton, EFLM is promoting a bursary programme for young scientists EFLM Academy Members specifically from Albania, Bosnia and Herzegovina, Georgia, Kazakhstan, Kosovo, Montenegro, North Macedonia, Russian Federation, Serbia and Ukraine attending the 24th IFCC-EFLM European Congress of Clinical Chemistry Laboratory Medicine in Munich from 28 November to 2 December 2021.
A limited number of bursaries is available, the bursaries will cover the cost of the travel and 4-night accommodation for a maximum of Eur 1.000,00. EFLM bursary recipients will also receive the free congress registration waived by the Congress Organizing Committee.
Eligible candidates should meet the following criteria:
Applications must be submitted through the specific application form (click here to download it) and accompanied by the following documentation:
Applications have to be sent to silvia.cattaneo@eflm.eu within October 5, 2021.
Please note that according to the EFLM Transparency Policy, all bursaries applicants’ names, evaluation ranking and reasons for that ranking will be made available to every bursaries applicant.
Professor of Laboratory Medicine at the University of California, San Francisco, and Co-Core Laboratory Director at the Zuckerberg San Francisco General Hospital.
Col (Dr) Mithu Banerjee pursued her MBBS & MD from Armed Forces Medical College (AFMC), Pune. She has worked in the Army Medical Corps for twenty four years . During her stint in the Armed Forces she held various prestigious appointments like Prof &HoD& Lab Director of Department of Biochemistry at AFMC, Senior Adviser (Pathology & Biochemistry) of Northern Command and Southern Command. She was instrumental in getting the Lab at AFMC National Accreditation Board of Laboratories accreditation,which was the first government lab to be accredited by NABL.She is a postgraduate & undergraduate examiner. She has memberships in international bodies like American Association of Clinical Chemistry & International Federation of Clinical Chemistry.
DrMithu Banerjee was awarded MNAMS in 2014. Dr Banerjee has pursued a postdoctral fellowship at the prestigious Johns Hopkins Medical Institute in cancer epigenetics in 2016. She was instrumental in starting work in cancer epigenetics in the Armed Forces. She has numerous publications in national& international Journals. She is also an instructor with the American Heart Association for Advanced & Basic Cardiac Life support. She has pursued an advanced course in Medical education from KEM hospital Mumbai. Presently she is working at AIIMS Jodhpur as Additional Professor at the Deptof Biochemistry.
